RxDoctor Payments Data

Andrew Li, MD

Hematology & Oncology · Frederick, MDNPI 1780189704

Payments from drug & device makers

$3,713in general payments, 2019–2025

Across 148 payments — averaging $25.09 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson$425
  • AbbVie$275
  • AstraZeneca$265
  • Merck$235
  • Novartis$231
  • GSK$184
  • plus $2K from 43 others

What the payments were for

  • Food & beverage$3,713100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$3,713 in reported general payments places this provider in the 40th percentile of 242 hematology & oncology providers in Maryland.

See all hematology & oncology providers in Maryland

Medicare billing

Part B allowed, 2024
$1,876,199
Medicare patients
408
Services billed
78,849

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Dexamethasone17$132
Ondansetron Hcl15$120

Paid to pharmacies, not to this prescriber.

Other hematology & oncology in Frederick

See the full list for Maryland

Where these figures come from

Is this you, or does something look wrong? →